Halozyme Therapeutics, Inc. (HALO)

NasdaqGS Currently up 0.74 (+1.10%) in today's trading session

Track congressional stock trades in Halozyme Therapeutics, Inc. (HALO). Analyze trading activity from Nancy Pelosi and other members of Congress with real-time financial disclosure data, interactive price charts, and detailed transaction records.

Halozyme Therapeutics, Inc. is currently trading at $67.82, positioned at 59% of its 52-week range ($47.50 – $82.22). View which politicians have recently bought or sold HALO and how their trades align with market movements.

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$67.82
24h Change
+0.74 (+1.10%)
52 Week Range
$47.50$82.22
View on NASDAQ

Halozyme Therapeutics, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for HALO

Select to highlight on chart
1 transactions
Compliance: 100%
Josh Gottheimer20 Aug 202120 Sept 2021PurchaseStock$1,001 - $15,000N/A (Price Data Unavailable)

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$8.03B

Volume

1M

Beta

1.03

P/E Ratio

26.49

Fundamentals

EPS

$2.56

Div. Yield

Open

$67.34

Day Range

$66.64 — $68.23

Company Information

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ · USD
Country
US
CEO
Helen I. Torley
IPO Date
2004-03-16

Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented reco...

Earnings

Next Report

Q1 2026

5 May

EPS Est.

$1.54

Rev. Est.

$358.5M

Days Until

23

Recent Quarters

Q4 202517 Feb
EPS$-0.24
Miss 111.2%
Q3 20253 Nov
EPS$1.72
Beat 5.5%
Q2 20255 Aug
EPS$1.54
Beat 25.2%
Q1 20256 May
EPS$1.11
Beat 16.8%
Q4 202418 Feb
EPS$1.26
Beat 7.7%
Q3 202431 Oct
EPS$1.27
Beat 29.6%
Q2 20246 Aug
EPS$0.91
Beat 19.7%
Q1 20247 May
EPS$0.79
Beat 12.9%
Q4 202320 Feb
EPS$0.82
Miss 1.2%
Q3 20236 Nov
EPS$0.75
Beat 5.6%
Q2 20238 Aug
EPS$0.74
Beat 17.5%
Q1 20239 May
EPS$0.47
Miss 2.1%
Q4 202221 Feb
EPS$0.48
Beat 2.1%
Q3 20228 Nov
EPS$0.74
Beat 42.3%
Q2 20229 Aug
EPS$0.53
Beat 6.0%
Q1 202210 May
EPS$0.47
Miss 4.1%
Q4 202122 Feb
EPS$0.42
Beat 2.4%
Q3 20212 Nov
EPS$0.55
Beat 30.9%
Q2 20219 Aug
EPS$0.62
Beat 51.2%
Q1 202110 May
EPS$0.37
Beat 19.4%
Q4 202023 Feb
EPS$0.50
Miss 5.7%
Q3 20202 Nov
EPS$0.25
Beat 31.6%
Q2 202010 Aug
EPS$0.19
Miss 24.0%
Q1 202011 May
EPS$-0.04
Miss 93.0%
Q4 201924 Feb
EPS$-0.24
Miss 33.3%
Q3 201912 Nov
EPS$-0.17
Miss 41.7%
Q2 20196 Aug
EPS$-0.10
Beat 41.2%
Q1 20197 May
EPS$0.01
Miss 28.1%
Q4 201821 Feb
EPS$-0.01
Miss 64.5%
Q3 20186 Nov
EPS$-0.19
Beat 17.4%
Q2 20187 Aug
EPS$-0.16
Beat 27.3%
Q1 201810 May
EPS$-0.19
Beat 9.5%
Q4 201720 Feb
EPS$0.85
Beat 18.1%
Q3 20177 Nov
EPS$0.02
Beat 120.0%
Q2 20178 Aug
EPS$-0.23
Beat 8.0%
Q1 20179 May
EPS$-0.26
Miss 4.0%
Q4 201628 Feb
EPS$-0.21
Beat 30.0%
Q3 20167 Nov
EPS$-0.23
Beat 14.8%
Q2 20169 Aug
EPS$-0.21
Beat 19.2%
Q1 20169 May
EPS$-0.16
Beat 27.3%
Q4 201529 Feb
EPS$0.03
Beat 142.9%
Q3 20159 Nov
EPS$-0.19
Miss 26.7%
Q2 201510 Aug
EPS$0.02
Beat 122.2%
Q1 201511 May
EPS$-0.12
Beat 7.7%
Q4 20142 Mar
EPS$-0.04
Beat 55.6%
Q3 201410 Nov
EPS$-0.16
Beat 0.0%
Q2 201411 Aug
EPS$-0.13
Beat 27.8%
Q1 201412 May
EPS$-0.22
Miss 37.5%
Q4 201327 Feb
EPS$-0.19
Miss 11.8%
Q3 20138 Nov
EPS$-0.17
Miss 21.4%
Q2 20137 Aug
EPS$-0.20
Miss 42.9%
Q1 20138 May
EPS$-0.17
Miss 13.3%
Q4 201225 Feb
EPS$-0.04
Beat 73.3%
Q3 20128 Nov
EPS$-0.18
Miss 28.6%
Q2 20126 Aug
EPS$-0.13
Beat 13.3%
Q1 20127 May
EPS$-0.14
Miss 27.3%
Q4 20119 Mar
EPS$-0.18
Miss 20.0%
Q3 20117 Nov
EPS$0.05
Beat 221.5%
Q2 20115 Aug
EPS$0.03
Beat 123.1%
Q1 20116 May
EPS$-0.10
Q1 20116 May
EPS$-0.10
Beat 16.7%
Q3 20105 Nov
EPS$-0.13
Beat 7.1%
Q2 20106 Aug
EPS$-0.13
Beat 7.1%
Q1 20107 May
EPS$-0.13
Beat 18.8%
Q4 200912 Mar
EPS$-0.14
Beat 17.6%
Q3 20096 Nov
EPS$-0.16
Beat 11.1%
Q2 20097 Aug
EPS$-0.21
Miss 23.5%
Q1 20098 May
EPS$-0.18
Miss 12.5%
Q4 200813 Mar
EPS$-0.21
Miss 61.5%
Q3 20086 Nov
EPS$-0.14
Miss 7.7%
Q2 20088 Aug
EPS$-0.14
Miss 7.7%
Q1 20088 May
EPS$-0.13
Miss 8.3%
Q4 200713 Mar
EPS$-0.11
Miss 37.5%
Q3 20078 Nov
EPS$-0.09
Miss 50.0%
Q2 20079 Aug
EPS$-0.07
Miss 55.6%
Q1 200710 May
EPS$-0.05
Beat 0.0%
Q4 20068 Mar
EPS$-0.07
Miss 16.7%
Q3 20069 Nov
EPS$-0.06
Beat 0.0%
Q2 200610 Aug
EPS$-0.05
Beat 0.0%
Q1 200610 May
EPS$-0.06
Miss 20.0%
Q4 200523 Mar
EPS$-0.07
Miss 16.7%
Q3 200511 Nov
EPS$-0.07
Miss 16.7%
Q2 20058 Aug
EPS$-0.06
Beat 0.0%
Q1 200513 May
EPS$-0.06
Beat 0.0%
Q4 20049 Mar
EPS$-0.05
Beat 28.6%
Q3 200412 Nov
EPS$-0.08
Miss 60.0%
Q2 200416 Aug
EPS$-0.05
Miss 25.0%
Q1 20041 Jun
EPS$-0.00
Beat 88.4%
Q1 200414 May
EPS$-0.08
Q3 200314 Nov
EPS$-0.00
Q2 200314 Aug
EPS$-0.00
Q1 200319 May
EPS$-0.00
Q1 20031 May
EPS$-0.02
Q3 200214 Nov
EPS$-0.01
Q2 200219 Aug
EPS$-0.01
Q1 200215 May
EPS$0.01

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations

NVDA

NVIDIA Corporation

20
$188.63+4.69 (+2.55%)
Technology
Held by same politician
Significant holdings value
1 politician
View Stock

PTSNX

PIMCO Short Term I-3

17
$9.680.00 (0.00%)
Held by same politician
1 politician
View Stock

NFLX

Netflix, Inc.

17
$103.01+0.92 (+0.90%)
Communication Services
Held by same politician
1 politician
View Stock
Pelosi TrackerJoin our Discord © 2026 - All rights reserved. This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.